Endoscopic therapy at referral centers is now an established treatment of Barrett’s esophagus related neoplasia including HGD and IMC in appropriately selected patients. Therefore, it is important to appreciate the difference between IMC versus submucosal invasion as this present study has done. One stated limitation of this study is the lack of standardized preoperative assessment. The 5.9% of cases with “occult” invasive cancer did not have any reported endoscopic or radiographic

findings suspicious for advanced disease. However, it is unclear what kind of endoscopic Inhibitors,research,lifescience,medical assessment was performed or what biopsy protocol, if any, was implemented in those cases. Although the authors concluded that their time based analysis did not reveal a decrease of prevalent disease with the increase of endoscopic technology and imaging, the presence of technology is perhaps insufficient to capture subtle disease. It is a systematic

protocol and ability to recognize suspicious lesions in conjunction with endoscopic imaging technology that Inhibitors,research,lifescience,medical enables endoscopists to target lesions for accurate diagnosis. Visible lesions in the setting of HGD are at high risk of harboring cancer until proven otherwise. The cornerstone of the endoscopic assessment in Barrett’s esophagus is a detailed white light examination with high resolution. The recognition of Inhibitors,research,lifescience,medical subtle lesions will enable the detection of disease. IWP-2 mouse Several studies have shown that visible lesions in the setting of HGD were associated with higher risk of occult cancer (25),(26). Furthermore, superficial lesions are being given more attention and a classification system is

now standardized (27). Protruding or depressed lesions are at higher risk for submucosal invasion than those slightly raised or flat areas Inhibitors,research,lifescience,medical Inhibitors,research,lifescience,medical (28),(29). Wang et al. described that all four cases of patient with submucosal invasive disease that was not previously diagnosed in their experience had nodular or ulcerated mucosa on endoscopy. Centers with experience with Barrett’s esophagus may use tools such as digital chromoendoscopy or confocal laser endomicroscopy to find unapparent or occult neoplasia (30). However, these technologies provide Sodium butyrate only an incremental yield over a detailed white light exam. The key is not just the tool itself, but the ability to recognize the lesions. Once a lesion is recognized as suspicious in the setting of a patient with Barrett’s esophagus with high grade dysplasia, a histological specimen is required to stage the lesion. Endoscopic mucosal resection (EMR) provides an opportunity to accurately stage the depth of a lesion in areas of question. There are significant limitations with endoscopic biopsy alone. Due to limited sample size and depth as well as potential crush artifact, pathologists may not reliably be able to distinguish between HGD, IMC, and submucosal carcinoma on a single endoscopic biopsy specimen.